Erythroid Neoplasm — Trials

Erythroid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 48
Recruiting: 25
Ph III recruiting: 7
Growth YoY: —
Industry share: 48%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (50)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07469891	A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms	recruiting	Phase 1	100	Prelude Therapeutics IncorporatedINDUSTRY	2	Sep 18, 2026	clinicaltrials
NCT07012109	Study of BEBT-507 Injection in Subjects With Polycythemia Vera (PV)	recruiting	Phase 1	90	BeBetter Med IncINDUSTRY	1	Aug 18, 2026	clinicaltrials